{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:35:21Z","timestamp":1792002921377,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jiac.2022.06.003","type":"journal-article","created":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T00:25:26Z","timestamp":1656116726000},"page":"1358-1363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Antimicrobial therapy, resistance, and appropriateness in healthcare-associated and community-associated infections; a point prevalence survey"],"prefix":"10.1016","volume":"28","author":[{"given":"Asim A.","family":"Alsaedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiman","family":"El-Saed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1684-5051","authenticated-orcid":false,"given":"Abdulhakeem","family":"Althaqafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Javid","family":"Bhutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassem","family":"Abukhzam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9961-8315","authenticated-orcid":false,"given":"Majid","family":"Alshamrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 5","key":"10.1016\/j.jiac.2022.06.003_bib1","first-page":"S397","article-title":"Combating antimicrobial resistance: policy recommendations to save lives","volume":"52","author":"Spellberg","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2022.06.003_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13756-019-0472-z","article-title":"Using the best available data to estimate the cost of antimicrobial resistance: a systematic review","volume":"8","author":"Wozniak","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.jiac.2022.06.003_bib3","series-title":"Global action plan on antimicrobial resistance. Geneva, Switzerland","author":"World Health Organization","year":"2015"},{"issue":"6","key":"10.1016\/j.jiac.2022.06.003_bib4","doi-asserted-by":"crossref","first-page":"e619","DOI":"10.1016\/S2214-109X(18)30186-4","article-title":"Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey","volume":"6","author":"Versporten","year":"2018","journal-title":"Lancet Global Health"},{"issue":"4","key":"10.1016\/j.jiac.2022.06.003_bib5","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/ijpp\/riab028","article-title":"Repeated point prevalence survey on antimicrobial use in a university hospital: what have we learned?","volume":"29","author":"Belan\u010di\u0107","year":"2021","journal-title":"Int J Pharm Pract"},{"issue":"8","key":"10.1016\/j.jiac.2022.06.003_bib6","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1093\/cid\/ciaa036","article-title":"Appropriateness of antibiotic prescribing in United States children's hospitals: a national point prevalence survey","volume":"71","author":"Tribble","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2022.06.003_bib7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijid.2020.09.1481","article-title":"Prevalence of infections and antimicrobial use in the acute-care hospital setting in the Middle East: results from the first point-prevalence survey in the region","volume":"101","author":"Alothman","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.jiac.2022.06.003_bib8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13756-020-00758-x","article-title":"The 2017 global point prevalence survey of antimicrobial consumption and resistance in Canadian hospitals","volume":"9","author":"Frenette","year":"2020","journal-title":"Antimicrob Resist Infect Control"},{"issue":"46","key":"10.1016\/j.jiac.2022.06.003_bib9","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.23.46.1800393","article-title":"Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017","volume":"23","author":"Plachouras","year":"2018","journal-title":"Euro Surveill"},{"issue":"1","key":"10.1016\/j.jiac.2022.06.003_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jiph.2018.09.003","article-title":"Point prevalence survey of antibiotic use in 26 Saudi hospitals in 2016","volume":"12","author":"Al Matar","year":"2019","journal-title":"J Infect Public Health"},{"issue":"3","key":"10.1016\/j.jiac.2022.06.003_bib11","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3390\/antibiotics3030450","article-title":"A point prevalence survey of antibiotic use in 18 hospitals in Egypt","volume":"3","author":"Talaat","year":"2014","journal-title":"Antibiotics (Basel)"},{"issue":"9","key":"10.1016\/j.jiac.2022.06.003_bib12","article-title":"Antimicrobial consumption and resistance in a tertiary care hospital in Jordan: results of an internet-based global point prevalence survey","volume":"9","author":"Abu Hammour","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jiac.2022.06.003_bib13","series-title":"NHSN manual. Patient safety component protocol","year":"2017"},{"key":"10.1016\/j.jiac.2022.06.003_bib14","series-title":"Point prevalence survey of healthcareassociated infections and antimicrobial use in European acute care hospitals 2011\u20132012","year":"2013"},{"issue":"2","key":"10.1016\/j.jiac.2022.06.003_bib15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4065\/mcp.2010.0639","article-title":"General principles of Antimicrobial therapy","volume":"86","author":"Leekha","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jiac.2022.06.003_bib16","series-title":"The antimicrobial stewardship program working group","year":"2012"},{"key":"10.1016\/j.jiac.2022.06.003_bib17","series-title":"The Sanford guide to antimicrobial therapy","year":"2017"},{"issue":"11","key":"10.1016\/j.jiac.2022.06.003_bib19","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1017\/ice.2016.174","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the national healthcare safety Network at the centers for disease control and prevention, 2011\u20132014","volume":"37","author":"Weiner","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"10.1016\/j.jiac.2022.06.003_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/668770","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the national healthcare safety Network at the centers for disease control and prevention, 2009\u20132010","volume":"34","author":"Sievert","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jiac.2022.06.003_bib21","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13756-018-0451-9","article-title":"Antimicrobial consumption in five adult intensive care units: a 33-month surveillance study","volume":"7","author":"Balkhy","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.jiac.2022.06.003_bib22","first-page":"1","article-title":"Epidemiology of extended-spectrum beta-lactamases (ESBLs)-Producing bacteria in different regions in Saudi Arabia: a systematic review","author":"Al-Ghamdi","year":"2018","journal-title":"Annual Research & Review in Biology"},{"issue":"4","key":"10.1016\/j.jiac.2022.06.003_bib23","first-page":"295","article-title":"Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings","volume":"3","author":"Khanfar","year":"2009","journal-title":"J Infect Dev Ctries"},{"issue":"1","key":"10.1016\/j.jiac.2022.06.003_bib24","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.sjbs.2014.08.002","article-title":"Antibiotic resistance and extended spectrum beta-lactamases: types, epidemiology and treatment","volume":"22","author":"Shaikh","year":"2015","journal-title":"Saudi J Biol Sci"},{"issue":"6","key":"10.1016\/j.jiac.2022.06.003_bib25","first-page":"1365","article-title":"Faecal carriage of extended-spectrum beta-lactamase-producing bacteria in the community","volume":"15","author":"Kader","year":"2009","journal-title":"East Mediterr Health J"},{"key":"10.1016\/j.jiac.2022.06.003_bib26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jgar.2020.07.013","article-title":"High burden of resistant gram negative pathogens causing device-associated healthcare infections in a tertiary care setting in Saudi Arabia, 2008-2016","volume":"23","author":"Balkhy","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"issue":"1","key":"10.1016\/j.jiac.2022.06.003_bib27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12879-020-4939-6","article-title":"High contribution and impact of resistant gram negative pathogens causing surgical site infections at a multi-hospital healthcare system in Saudi Arabia, 2007-2016","volume":"20","author":"El-Saed","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"11","key":"10.1016\/j.jiac.2022.06.003_bib28","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1007\/s10096-021-04288-1","article-title":"Profiles of multidrug-resistant organisms among patients with bacteremia in intensive care units: an international ID-IRI survey","volume":"40","author":"El-Sokkary","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"11","key":"10.1016\/j.jiac.2022.06.003_bib29","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.jsps.2020.09.015","article-title":"Evaluating the appropriateness of carbapenem and piperacillin-tazobactam prescribing in a tertiary care hospital in Saudi Arabia","volume":"28","author":"Alsaleh","year":"2020","journal-title":"Saudi Pharmaceut J"},{"issue":"1","key":"10.1016\/j.jiac.2022.06.003_bib30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13756-020-00842-2","article-title":"Evaluating antimicrobial appropriateness in a tertiary care pediatric ICU in Saudi Arabia: a retrospective cohort study","volume":"9","author":"Kazzaz","year":"2020","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.jiac.2022.06.003_bib31","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s13756-019-0609-0","article-title":"Appropriateness of antimicrobial use among septic patients managed by the critical care response team: an opportunity for improvement through de-escalation","volume":"8","author":"Al-Qahtani","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"issue":"7","key":"10.1016\/j.jiac.2022.06.003_bib32","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/CCM.0000000000004344","article-title":"Opportunities to improve antibiotic appropriateness in U.S. ICUs: a multicenter evaluation","volume":"48","author":"Trivedi","year":"2020","journal-title":"Crit Care Med"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X22001787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X22001787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:04:31Z","timestamp":1761159871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X22001787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1341321X22001787"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2022.06.003","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial therapy, resistance, and appropriateness in healthcare-associated and community-associated infections; a point prevalence survey","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2022.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}